Revelation Biosciences In...
(REVB)
undefined
undefined%
At close: undefined
0.37
2.78%
Pre-market Dec 16, 2024, 04:48 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -120.25K | -10.83M | -11.99M | -1.63M | -3.64K |
| Depreciation & Amortization | 25.05K | 25.05K | 16.78K | - | - |
| Stock-Based Compensation | 155.72K | 301.12K | 470.88K | 43.85K | - |
| Other Working Capital | 232.47K | -64.93K | 625.86K | -80.50K | 3.64K |
| Other Non-Cash Items | -8.33M | 14.96K | 52.38K | 1.50M | - |
| Deferred Income Tax | - | - | - | - | - |
| Change in Working Capital | 982.13K | -730.97K | 356.22K | -80.50K | 3.64K |
| Operating Cash Flow | -7.29M | -11.22M | -11.09M | -215.07K | - |
| Capital Expenditures | -4 | - | -131.96K | - | - |
| Acquisitions | - | - | - | - | - |
| Purchase of Investments | - | - | - | -74.04M | - |
| Sales Maturities Of Investments | - | - | 525.29K | - | - |
| Other Investing Acitivies | - | - | -525.29K | -74.04M | - |
| Investing Cash Flow | - | - | -131.96K | -74.04M | - |
| Debt Repayment | - | -796.88K | - | 15.00K | - |
| Common Stock Repurchased | -5.00K | -7.65M | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | -4.97K | 11.54M | 7.40M | -65.40M | 10.00K |
| Financial Cash Flow | 14.03M | 15.20M | 8.00M | 74.26M | - |
| Net Cash Flow | 6.74M | 3.98M | -3.22M | -74.23M | - |
| Free Cash Flow | -7.29M | -11.22M | -11.22M | -215.07K | - |